CompletedNot Applicable

Validation of the GIDS and Description of Phosphate Disorders

Estonia2,681 participantsStarted 2024-01-08

Plain-language summary

This study will address two specific research questions simultaneously: 1. validation of the GastroIntestinal (GI) Dysfunction score (GIDS). 2. description of epidemiology, risk factors, and management of phosphate disorders. The aim is to recruit 20 ICUs and 1500 ICU patients. Sites will recruit all consecutive adult patients to a maximum of 120 patients or a maximum recruitment period of 8 weeks, whichever comes first. Daily data collection on gastrointestinal signs and symptoms as well as phosphate values and management will be collected during ICU stay for maximum of 7 days. 28 and 90 day mortality and days free of organ support will be the main outcomes. Secondary outcomes include prevalence of hypo- and hyperphosphatemia and description of their management.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Admission to ICU during the study period * Age ≥18 years Exclusion Criteria: * Age \<18 years; * Patients with restrictions of care such as "no intubation" or "no renal replacement therapy" on ICU admission and patients admitted for treatment as organ donors; * Continuous chronic home ventilation for neuromuscular disease; * Declined participation or informed consent (if the local ethics committee requests the latter for this non-interventional study); * Readmission to ICU during the study period

What they're measuring

90 days mortality

Timeframe: 90 days

28 days mortality

Timeframe: 28 days

Trial details

NCT IDNCT05909722

SponsorUniversity of Tartu

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-20

View on ClinicalTrials.gov More Organ Dysfunction Scores trials